{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:10:21Z","timestamp":1792455021672,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012323","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000}}],"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>American Cutaneous Leishmaniasis (ACL) shows variable response to therapy, but data on species-specific treatment efficacy is scarce. We describe the clinical characteristics and outcome of patients with ACL imported to a tertiary centre in Germany and determine whether species-specific therapy according to the 2014 \u201cLeishMan\u201d group recommendations is associated with cure.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective chart review was conducted at the Charit\u00e9 Institute of International Health in Berlin. We analysed data on PCR-confirmed ACL cases collected between 2000 and 2023. Systemic therapy included liposomal amphotericin B, miltefosine, pentavalent antimony, ketoconazole or itraconazole. Localized therapy included perilesional pentavalent antimony or paromomycin ointment. Cure was defined as re-epithelialization of ulcers or disappearance of papular-nodular lesions after 3 months of treatment. Logistic regression models were used to quantify the effect of species-specific systemic therapy on the outcome.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>75 cases were analysed. Most patients were male (62%), median age was 35 years, no patient had a history of immunosuppression. The most common reason for travel was tourism (60%), the most common destination was Costa Rica (28%), the median duration of illness was 8 weeks, and most patients presented with ulcers (87%). Lesions were complex in 43%. The most common <jats:italic>Leishmania<\/jats:italic> (L.) species was <jats:italic>L<\/jats:italic>. <jats:italic>braziliensis<\/jats:italic> (28%), followed by <jats:italic>L<\/jats:italic>. <jats:italic>panamensis<\/jats:italic> (21%). 51\/73 (70%) patients were cured after initial therapy and 17\/21 (81%) after secondary therapy. Cure after systemic therapy was more frequent when species-specific treatment recommendations were followed (33\/45; 73%), compared to when not followed, (6\/17; 35%, P = 0.008). This association was independent of age, sex, previous therapy, complex lesions, and <jats:italic>Leishmania<\/jats:italic> species (adjusted OR, 5.06; 95% CI, 1.22\u201324.16).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>ACL is a rare, imported disease in Germany. Complex lesions were common, challenging successful therapy. This study highlights the importance of identifying the parasite species and suggests that a species-specific approach to treatment leads to better outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0012323","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T17:41:44Z","timestamp":1721065304000},"page":"e0012323","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["American Cutaneous Leishmaniasis: Imported cases in Berlin 2000\u20132023"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5768-5109","authenticated-orcid":true,"given":"Andreas K.","family":"Lindner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Moreno-del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Wintel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Equihua Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieder","family":"Pf\u00e4fflin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Gertler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Georgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"H\u00fclso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Konopelska","family":"Kotsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Seigerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welmoed","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-4709","authenticated-orcid":true,"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundel","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"2","key":"pntd.0012323.ref001","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.","volume":"21","author":"J Blum","year":"2014","journal-title":"J Travel Med"},{"issue":"2","key":"pntd.0012323.ref002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40121-022-00602-2","article-title":"Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review.","volume":"11","author":"RK Madusanka","year":"2022","journal-title":"Infect Dis Ther."},{"issue":"40","key":"pntd.0012323.ref003","first-page":"S394","article-title":"Surveillance of leishmaniasis in the WHO European Region and Global leishmaniasis surveillance update, 1998\u20132016.","volume":"66","author":"A Fahrion","year":"2018","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"5","key":"pntd.0012323.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence.","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One."},{"key":"pntd.0012323.ref005","author":"World Health Organization","year":"2023","journal-title":"Leishmaniasis"},{"issue":"98","key":"pntd.0012323.ref006","first-page":"471","article-title":"Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years.","volume":"40","author":"JA Ruiz-Postigo","year":"2023","journal-title":"Weekly Epidemiological Record"},{"key":"pntd.0012323.ref007","first-page":"43","volume-title":"Leishmaniasis in the Americas: Treatment recommendations","author":"Pan American Health Organization","year":"2018"},{"issue":"12","key":"pntd.0012323.ref008","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).","volume":"63","author":"N Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0012323.ref009","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0732-8893(03)00093-2","article-title":"PCR diagnosis and characterization of Leishmania in local and imported clinical samples","volume":"47","author":"G Sch\u00f6nian","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"pntd.0012323.ref010","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10096-011-1463-z","article-title":"Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification","volume":"31","author":"AM Montalvo","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"pntd.0012323.ref011","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pt.2010.06.013","article-title":"Is it time to revise the nomenclature of Leishmania?","volume":"26","author":"G Sch\u00f6nian","year":"2010","journal-title":"Trends Parasitol"},{"issue":"3","key":"pntd.0012323.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002130","article-title":"Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis.","volume":"7","author":"P Olliaro","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"issue":"1","key":"pntd.0012323.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006141","article-title":"Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.","volume":"12","author":"P Olliaro","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0012323.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0009863","article-title":"Clinical diversity and treatment results in tegumentary leishmaniasis: A European clinical report in 459 patients.","volume":"15","author":"R Guery","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0012323.ref015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.","volume":"4","author":"J Blum","year":"2012","journal-title":"Int Health."},{"key":"pntd.0012323.ref016","doi-asserted-by":"crossref","first-page":"101885","DOI":"10.1016\/j.tmaid.2020.101885","article-title":"Epidemiology, clinical pattern and impact of species-specific molecular diagnosis on management of leishmaniasis in Belgium, 2010\u20132018: A retrospective study.","volume":"38","author":"M Vandeputte","year":"2020","journal-title":"Travel Med Infect Dis."},{"key":"pntd.0012323.ref017","first-page":"3","article-title":"A definition of causal effect.","author":"MA Hern\u00e1n","year":"2020","journal-title":"Causal Inference What If."},{"issue":"6","key":"pntd.0012323.ref018","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: The R package \u201cdagitty.\u201d","volume":"45","author":"J Textor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"pntd.0012323.ref019","author":"M Pinart","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pntd.0012323.ref020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.idc.2018.10.004","article-title":"Cutaneous Leishmaniasis: Updates in Diagnosis and Management.","volume":"33","author":"NE Aronson","year":"2019","journal-title":"Infect Dis Clin North Am."},{"issue":"7","key":"pntd.0012323.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofad348","article-title":"Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis.","volume":"10","author":"J Chivinski","year":"2023","journal-title":"Open Forum Infect Dis."},{"issue":"5","key":"pntd.0012323.ref022","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis","volume":"83","author":"J Pierson","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"pntd.0012323.ref023","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1365-4632.2011.04987.x","article-title":"Treatment of imported New World cutaneous leishmaniasis in Germany","volume":"50","author":"G Harms","year":"2011","journal-title":"Int J Dermatol"},{"issue":"11","key":"pntd.0012323.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006094","article-title":"Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.","volume":"11","author":"R Guery","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"September","key":"pntd.0012323.ref025","first-page":"1","article-title":"Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area","volume":"12","author":"DH Barroso","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"pntd.0012323.ref026","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.","volume":"86","author":"LO Neves","year":"2011","journal-title":"An Bras Dermatol."},{"issue":"7","key":"pntd.0012323.ref027","doi-asserted-by":"crossref","first-page":"E2457","DOI":"10.1093\/cid\/ciaa1238","article-title":"Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis","volume":"73","author":"JAM Ware","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pntd.0012323.ref028","doi-asserted-by":"crossref","first-page":"E2463","DOI":"10.1093\/cid\/ciaa1461","article-title":"Miltefosine Treatment of Cutaneous Leishmaniasis","volume":"73","author":"JA Soto","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pntd.0012323.ref029","first-page":"1","article-title":"Why miltefosine\u2014A life-saving drug for leishmaniasis-is unavailable to people who need it the most","volume":"3","author":"T Sunyoto","year":"2018","journal-title":"BMJ Glob Heal"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012323","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T17:52:07Z","timestamp":1721929927000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012323"}},"subtitle":[],"editor":[{"given":"Dario S.","family":"Zamboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012323","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0012323","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]}}}